Viveve Medical (NASDAQ:VIVE) reported quarterly losses of $(0.67) per share which met the analyst consensus estimate. This is a 16.25 percent increase over losses of $(0.80) per share from the same period last year. The company reported quarterly sales of $1.60 million which missed the analyst consensus estimate of $1.73 million by 7.51 percent. This is a 10.34 percent increase over sales of $1.45 million the same period last year.
Viveve Medical Q1 EPS $(0.67), Inline, Sales $1.60M Miss $1.73M Estimate
Viveve Medical (NASDAQ:VIVE) reported quarterly losses of $(0.67) per share which met the analyst consensus estimate. This is a 16.25 percent increase over losses of $(0.80) per share from the same period last year. The
